The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis.
Int J Immunopathol Pharmacol
; 34: 2058738420961304, 2020.
Article
in English
| MEDLINE | ID: covidwho-1067161
ABSTRACT
COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically associated with a hyper-immune response, also referred to as a 'cytokine storm'. Probiotics are living microorganisms that have been shown to have positive effects on immune response in man with some bacteria; some strains of Bifidobacteria, for example, possess especially potent immune modulating effects. These bacteria have the potential to ameliorate the 'cytokine storm' through a differential effect on pro- and anti-inflammatory cytokines. In the management of COVID-19 and other coronovirus-mediated illnesses, probiotic bacteria also have the potential to enhance vaccine efficacy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Bifidobacterium
/
Coronavirus Infections
/
Probiotics
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Int J Immunopathol Pharmacol
Journal subject:
Allergy and Immunology
/
Pharmacology
/
Pathology
Year:
2020
Document Type:
Article
Affiliation country:
2058738420961304
Similar
MEDLINE
...
LILACS
LIS